NOVAPHARM HEALTHCARE

Medicine.
Where it needs to be.

Connecting specialist medicines, market access and regulatory judgement through a more considered pharmaceutical model.

Explore NovaPharm Partner with us
Illustrative pharmaceutical supply network visual

WHY NOVAPHARM

Better access begins with better decisions.

Medicine is already moving. The questions that matter are where it needs to go, what evidence supports it, and what permissions make responsible access possible.

ONCOLOGY & SPECIALIST MEDICINES

Specialist medicines.
Uncompromising standards.

Every opportunity is evaluated against formulation, supply continuity, source quality and product-specific regulatory evidence.

Explore oncology
Representative controlled pharmaceutical laboratory handling

NUTRAXIN & PORTFOLIO

Thoughtfully selected.
Carefully presented.

Explore approved catalogue imagery for Nutraxin and the strategic categories NovaPharm is evaluating.

Nutraxin Vitamin D3 1000 IU box and 120-tablet bottleNutraxin Vitamin D3120 tabletsNutraxin Vitamin C 1000 mg box and 30-tablet bottleNutraxin Vitamin C 1000 mg30 tabletsNutraxin Gold Quality Collagen box and 30-tablet bottleNutraxin Gold Quality Collagen30 tablets
Explore Nutraxin Strategic pharmaceutical portfolio

Catalogue information is for qualified review. Pricing, stock, medicinal status and supply availability are not asserted.

NOVAPHARM INTELLIGENCE

Understand the medicine.
Understand the market.

We are building a governed intelligence experience to connect medicines, evidence, market information and explainable analysis.

Explore our technology direction

In development. The adjacent graphic is an artistic concept, not a working interface or validated forecast.

SOURCING & MARKET ACCESS

Three routes.
One evidence standard.

Commercial opportunity should never move faster than the permissions and quality evidence behind it.

01

Direct GMP partnerships

Qualified manufacturer relationships with controlled technical and quality review.

02

Product-specific PLPI

Evidence-led assessment of appropriate MHRA parallel-import pathways and obligations.

03

European sourcing

Potential authorised routes reviewed for rights, licence standing, provenance and continuity.

Explore capabilities

QUALITY & REGULATORY FOUNDATION

Built for trust.
Designed for scrutiny.

Product rights, WDA(H) readiness, GDP controls, vendor oversight and traceable records must align before any regulated release.

Regulatory & quality

QUALIFIED PARTNERSHIPS

Let's build something meaningful.

For manufacturers, product owners, authorised supply partners and organisations pursuing better market access.

Contact NovaPharm Partnerships

Qualified B2B information only. An enquiry does not confirm authorisation, availability or permission to supply.